T1	Participants 564 597	pregnant women infected with HIV.
T2	Participants 606 711	Pregnant women with WHO stage 1, 2, or 3 HIV-1 infection who had CD4 cell counts of 200-500 cells per Î¼L
T3	Participants 746 838	in Burkina Faso, Kenya, and South Africa to start study treatment at 28-36 weeks' gestation.
T4	Participants 1444 1455	All infants
T5	Participants 1992 2058	FINDINGS From June, 2005, to August, 2008, 882 women were enrolled
T6	Participants 2103 2146	to 805 singleton or first, liveborn infants
